Mass spectrometric identification of novel lysine acetylation sites in Huntingtin

Molecular and Cellular Proteomics

Volumn 10, Issue 10, 2011, Pages

  Cong, Xin ^a   Held, Jason M ^a   DeGiacomo, Francesco ^a   Bonner, Akilah ^a   Chen, Jan Marie ^a   Schilling, Birgit ^a   Czerwieniec, Gregg A ^a   Gibson, Bradford W ^a   Ellerby, Lisa M ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; HUNTINGTIN; LYSINE; MYC PROTEIN; POLYGLUTAMINE; ANTIBODY; HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; WILD TYPE; ANIMAL; BRAIN; CELL STRAIN HEK293; CHEMISTRY; GENETICS; MASS SPECTROMETRY; METABOLISM; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE;

ACETYLATION; ANIMALS; ANTIBODIES; BRAIN; DISEASE PROGRESSION; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HUNTINGTON DISEASE; LYSINE; MASS SPECTROMETRY; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY;

EID: 80054036817     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.009829     Document Type: Article

References (84)

1. The Huntington's Disease Research Group, H. D. C. R. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983
2. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P., Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577 (Pubitemid 16196286)
3. Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., MacDonald, M., Fossale, E., Zeitlin, S., Buckley, N., and Cattaneo, E. (2007) Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 6972-6983 (Pubitemid 47015906)
4. Gafni, J., Hermel, E., Young, J. E., Wellington, C. L., Hayden, M. R., and Ellerby, L. M. (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J. Biol. Chem. 279, 20211-20220 (Pubitemid 38623466)
5. Cha, J. H. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387-392
6. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810 (Pubitemid 39434070)
7. Bae, B. I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., Snyder, S. H., and Sawa, A. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29-41 (Pubitemid 40922848)
8. Dunah, A. W., Jeong, H., Griffin, A., Kim, Y. M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243 (Pubitemid 34680312)
9. Freiman, R. N., and Tjian R. (2002) Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science 296, 2149-2150 (Pubitemid 34680278)
10. Graham, R. K., Deng, Y., Slow, E. J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., Warby, S. C., Doty, C. N., Roy, S., Wellington, C. L., Leavitt, B. R., Raymond, L. A., Nicholson, D. W., and Hayden, M. R. (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179-1191 (Pubitemid 43866195)
11. Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z. H., Aronin, N., and DiFiglia, M. (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. U.S.A. 98, 12784-12789 (Pubitemid 33020022)
12. Chen-Plotkin, A. S., Sadri-Vakili, G., Yohrling, G. J., Braveman, M. W., Benn, C. L., Glajch, K. E., DiRocco, D. P., Farrell, L. A., Krainc, D., Gines, S., MacDonald, M. E., and Cha, J. H. (2006) Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol. Dis. 22, 233-241
13. Cornett, J., Smith, L., Friedman, M., Shin, J. Y., Li, X. J., and Li, S. H. (2006) Context-dependent dysregulation of transcription by mutant huntingtin. J. Biol. Chem. 281, 36198-36204 (Pubitemid 46041354)
14. Rangone, H., Poizat, G., Troncoso, J., Ross, C. A., MacDonald, M. E., Saudou, F., and Humbert, S. (2004) The serum- and glucocorticoidinduced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur. J. Neurosci. 19, 273-279 (Pubitemid 38177866)
15. Borrell-Pagès, M., Zala, D., Humbert, S., and Saudou, F. (2006) Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63, 2642-2660 (Pubitemid 44800717)
16. Diaz-Hernández, M., Valera, A. G., Morán, M. A., Gómez-Ramos, P., Alvarez- Castelao, B., Castaño, J. G., Hernández, F., and Lucas, J. J. (2006) Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J. Neurochem. 98, 1585-1596
17. Dorval, V., and Fraser, P. E. (2007) SUMO on the road to neurodegeneration. Biochim. Biophys. Acta 1773, 694-706 (Pubitemid 46830946)
18. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66
19. Humbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., Greenberg, M. E., and Saudou, F. (2002) The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell 2, 831-837 (Pubitemid 34650078)
20. Schilling, B., Gafni, J., Torcassi, C., Cong, X., Row, R. H., LaFevre-Bernt, M. A., Cusack, M. P., Ratovitski, T., Hirschhorn, R., Ross, C. A., Gibson, B. W., and Ellerby, L. M. (2006) Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. J. Biol. Chem. 281, 23686-23697 (Pubitemid 44274144)
21. Luo, S., Vacher, C., Davies, J. E., and Rubinsztein, D. C. (2005) Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J. Cell Biol. 169, 647-656 (Pubitemid 41002857)
22. Anne, S. L., Saudou, F., and Humbert, S. (2007) Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J. Neurosci. 27, 7318-7328 (Pubitemid 47037570)
23. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., Illes, K., Lukacsovich, T., Zhu, Y. Z., Cattaneo, E., Pandolfi, P. P., Thompson, L. M., and Marsh, J. L. (2004) SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104 (Pubitemid 38451465)
24. Kalchman, M. A., Graham, R. K., Xia, G., Koide, H. B., Hodgson, J. G., Graham, K. C., Goldberg, Y. P., Gietz, R. D., Pickart, C. M., and Hayden, M. R. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem. 271, 19385-19394 (Pubitemid 26271610)
25. Davie, J. R., and Spencer, V. A. Control of histone modifications. J. Cell. Biochem. Suppl 32-33:141-148, 1999 (Pubitemid 30041820)
26. Spencer, V. A., and Davie, J. R. (1999) Role of covalent modifications of histones in regulating gene expression. Gene 240, 1-12 (Pubitemid 29516431)
27. Kouzarides, T. (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179
28. Yang, X. J., and Seto, E. (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310-5318
29. Kuo, M. H., and Allis, C. D. (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20, 615-626
30. Shahbazian, M. D., and Grunstein, M. (2007) Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100
31. Williams, S. K., Truong, D., and Tyler, J. K. (2008) Acetylation in the globular core of histone H3 on lysine-56 promotes chromatin disassembly during transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 105, 9000-9005
32. Fu, M., Wang, C., Zhang, X., and Pestell, R. G. (2004) Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem. Pharmacol. 68, 1199-1208 (Pubitemid 39094285)
33. Roh, M. S., Kim, C. W., Park, B. S., Kim, G. C., Jeong, J. H., Kwon, H. C., Suh, D. J., Cho, K. H., Yee, S. B., and Yoo, Y. H. (2004) Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells. Apoptosis 9, 583-589 (Pubitemid 39158634)
34. Balakin, K. V., Ivanenkov, Y. A., Kiselyov, A. S., and Tkachenko, S. E. (2007) Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med. Chem. 7, 576-592 (Pubitemid 351836128)
35. Zhang, J., Sprung, R., Pei, J., Tan, X., Kim, S., Zhu, H., Liu, C. F., Grishin, N. V., and Zhao, Y. (2009) Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol. Cell Proteomics 8, 215-225
36. Aoki, E., and Schultz, R. M. (1999) DNA replication in the 1-cell mouse embryo: stimulatory effect of histone acetylation. Zygote 7, 165-172
37. Chen, C. C., and Tyler, J. (2008) Chromatin reassembly signals the end of DNA repair. Cell Cycle 7, 3792-3797
38. Chen, H., Schuster, M. C., Sfyroera, G., Geisbrecht, B. V., and Lambris, J. D. (2008) Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry. J. Am. Soc. Mass Spectrom. 19, 55-65
39. Escargueil, A. E., Soares, D. G., Salvador, M., Larsen, A. K., and Henriques, J. A. (2008) What histone code for DNA repair? Mutat. Res. 658, 259-270
40. Block-Galarza, J., Chase, K. O., Sapp, E., Vaughn, K. T., Vallee, R. B., DiFiglia, M., and Aronin, N. (1997) Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport 8, 2247-2251 (Pubitemid 27319681)
41. Huen, M. S., and Chen, J. (2008) The DNA damage response pathways: at the crossroad of protein modifications. Cell Res. 18, 8-16
42. Borchers, A., Braspenning, J., Meijer, J., Osen, W., Gissmann, L., and Jochmus, I. (1999) E7-specific cytotoxic T cell tolerance in HPV-transgenic mice. Arch. Virol. 144, 1539-1556 (Pubitemid 29437439)
43. Muftuoglu, M., Kusumoto, R., Speina, E., Beck, G., Cheng, W. H., and Bohr, V. A. (2008) Acetylation regulates WRN catalytic activities and affects base excision DNA repair. PLoS ONE 3, e1918
44. O'Connor, M. J., Martin, N. M., and Smith, G. C. (2007) Targeted cancer therapies based on the inhibition of DNA strand break repair. Oncogene 26, 7816-7824 (Pubitemid 350242461)
45. Chiang, M. C., Chen, H. M., Lee, Y. H., Chang, H. H., Wu, Y. C., Soong, B. W., Chen, C. M., Wu, Y. R., Liu, C. S., Niu, D. M., Wu, J. Y., Chen, Y. T., and Chern, Y. (2007) Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum. Mol. Genet. 16, 483-498
46. Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J., and Zhao, Y. (2006) Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607-618 (Pubitemid 44205490)
47. Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., and Contestabile, A. (Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox. Res. 17, 130-141
48. Kilgore, M., Miller, C. A., Fass, D. M., Hennig, K. M., Haggarty, S. J., Sweatt, J. D., and Rumbaugh, G. (Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880
49. Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A., Steffan, J. S., Marsh, J. L., Thompson, L. M., Lewis, C. M., Marks, P. A., and Bates, G. P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 2041-2046 (Pubitemid 36254570)
50. Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., and Hersch, S. M. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 23, 9418-9427 (Pubitemid 37323042)
51. Feng, H. L., Leng, Y., Ma, C. H., Zhang, J., Ren, M., and Chuang, D. M. (2008) Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155, 567-572
52. Butler, R., and Bates, G. P. (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat. Rev. Neurosci. 7, 784-796 (Pubitemid 44435261)
53. Bridges, K. R., Schmidt, G. J., Jensen, M., Cerami, A., and Bunn, H. F. (1975) The acetylation of hemoglobin by aspirin. In vitro and in vivo. J. Clin. Invest. 56, 201-207
54. Schmitt, M., and Matthies, H. (1979) [Biochemical studies on histones of the central nervous system. I. Characterization and partial identification of the label of histones from rat brain following intraventricular administration of 1-[14C]-acetate]. Acta Biol. Med. Ger. 38, 673-676 (Pubitemid 10216372)
55. Qiang, L., Xiao, H., Campos, E. I., Ho, V. C., and Li, G. (2005) Development of a PAN-specific, affinity-purified anti-acetylated lysine antibody for detection, identification, isolation, and intracellular localization of acetylated protein. J. Immunoassay Immunochem. 26, 13-23 (Pubitemid 40250342)
56. Chen, L. F., and Greene, W. C. (2005) Assessing acetylation of NF-kappaB. Methods 36, 368-375
57. Kouach, M., Belaïche, D., Jaquinod, M., Couppez, M., Kmiecik, D., Ricart, G., Van Dorsselaer, A., Sautière, P., and Briand, G. (1994) Application of electrospray and fast atom bombardment mass spectrometry to the identification of post-translational and other chemical modifications of proteins and peptides. Biol. Mass Spectrom. 23, 283-294
58. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., and Fotsis, T., Mann, M. (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466-469
59. Siuti, N., and Kelleher, N. L. (2007) Decoding protein modifications using top-down mass spectrometry. Nat. Methods 4, 817-821 (Pubitemid 350055578)
60. Loo, J., andLoo, R. R. O. (1997) Electrospray Ionization Mass Spectrometry, ed Cole, R. B. (John Wiley, New York), pp 385-419
61. Winston, R., and Fitzgerald, M. (1996) Mass spectrometry as a readout of protein structure and function Mass Spectrometry Rev. 379, 466-469
62. Witze, E. S., Old, W. M., Resing, K. A., and Ahn, N. G. (2007) Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 4, 798-806 (Pubitemid 350055576)
63. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
64. Falick, A. M., Hines, W. M., Medzihradszky, K. F., Baldwin, M. A., and Gibson, B. W. (1993) Low-mass ions produced from peptides by high-energy collision-induced dissociation in tandem mass spectrometry J. Am. Soc. Mass Spectrom. 4, 882-893
65. Borchers, M. T., Wesselkamper, S., Wert, S. E., Shapiro, S. D., and Leikauf, G. D. (1999) Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am. J. Physiol. 277, L489-497 (Pubitemid 29459668)
66. Schilling, B., Row, R. H., Gibson, B. W., Guo, X., and Young, M. M. (2003) MS2Assign, automated assignment and nomenclature of tandem mass spectra of chemically crosslinked peptides. J. Am. Soc. Mass Spectrom. 14, 834-850 (Pubitemid 36904256)
67. Chen, R., Fearnley, I. M., Palmer, D. N., and Walker, J. E. (2004) Lysine 43 is trimethylated in subunit C from bovine mitochondrial ATP synthase and in storage bodies associated with batten disease. J. Biol. Chem. 279, 21883-21887 (Pubitemid 38679377)
68. Zhang, K., Williams, K. E., Huang, L., Yau, P., Siino, J. S., Bradbury, E. M., Jones, P. R., Minch, M. J., and Burlingame, A. L. (2002) Histone acetylation and deacetylation: identification of acetylation and methylation sites of HeLa histone H4 by mass spectrometry. Mol. Cell Proteomics 1, 500-508
69. Cocklin, R. R., and Wang, M. (2003) Identification of methylation and acetylation sites on mouse histone H3 using matrix-assisted laser desorption/ ionization time-of-flight and nanoelectrospray ionization tandem mass spectrometry. J. Protein Chem. 22, 327-334 (Pubitemid 37087793)
70. Chen, C., Zhou, Z., Guo, P., and Dong, J. T. (2007) Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway. FEBS Lett. 581, 1124-1130 (Pubitemid 46394549)
71. Dormeyer, W., Ott, M., and Schnölzer, M. (2005) Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays. Mol. Cell Proteomics 4, 1226-1239 (Pubitemid 41448711)
72. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 (Pubitemid 30007252)
73. Stevens, S. M., Jr., Prokai-Tatrai, K., and Prokai, L. (2008) Factors that contribute to the misidentification of tyrosine nitration by shotgun proteomics. Mol. Cell Proteomics 7, 2442-2451
74. Jeong, H., Then, F., Melia, T. J., Jr., Mazzulli, J. R., Cui, L., Savas, J. N., Voisine, C., Paganetti, P., Tanese, N., Hart, A. C., Yamamoto, A., and Krainc, D. (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137, 60-72
75. Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V. N., Kazantsev, A., Marsh, J. L., Sullivan, P. G., Steffan, J. S., Sensi, S. L., and Thompson, L. M. (2007) The first 17 amino acids of Huntingtin modulate its subcellular localization, aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16, 61-77 (Pubitemid 46156597)
76. Ratovitski, T., Gucek, M., Jiang, H., Chighladze, E., Waldron, E., D'Ambola, J., Hou, Z., Liang, Y., Poirier, M. A., Hirschhorn, R. R., Graham, R., Hayden, M. R., Cole, R. N., and Ross, C. A. (2009) Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J. Biol. Chem. 284, 10855-10867
77. Lunkes, A., Lindenberg, K. S., Ben-Haïem, L., Weber, C., Devys, D., Landwehrmeyer, G. B., Mandel, J. L., and Trottier, Y. (2002) Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol. Cell 10, 259-269 (Pubitemid 35007341)
78. Wellington, C. L., Ellerby, L. M., Gutekunst, C. A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y. Z., Gafni, J., Bredesen, D., Hersch, S. M., Leavitt, B. R., Roy, S., Nicholson, D. W., and Hayden, M. R. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862-7872 (Pubitemid 35379091)
79. Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., Nicholson, D. W., Bredesen, D. E., and Hayden, M. R. (2000) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831-19838 (Pubitemid 30441585)
80. Gafni, J., and Ellerby, L. M. (2002) Calpain activation in Huntington's disease. J. Neurosci. 22, 4842-4849 (Pubitemid 37465599)
81. Gardian, G., Browne, S. E., Choi, D. K., Klivenyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B., Ratan, R. R., Ferrante, R. J., and Beal, M. F. (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J. Biol. Chem. 280, 556-563 (Pubitemid 40165021)
82. Thompson, L. M., Aiken, C. T., Kaltenbach, L. S., Agrawal, N., Illes, K., Khoshnan, A., Martinez-Vincente, M., Arrasate, M., O'Rourke, J. G., Khashwji, H., Lukacsovich, T., Zhu, Y. Z., Lau, A. L., Massey, A., Hayden, M. R., Zeitlin, S. O., Finkbeiner, S., Green, K. N., LaFerla, F. M., Bates, G., Huang, L., Patterson, P. H., Lo, D. C., Cuervo, A. M., Marsh, J. L., and Steffan, J. S. (2009) IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 187, 1083-1099
83. Kegel, K. B., Sapp, E., Yoder, J., Cuiffo, B., Sobin, L., Kim, Y. J., Qin, Z. H., Hayden, M. R., Aronin, N., Scott, D. L., Isenberg, G., Goldmann, W. H., and DiFiglia, M. (2005) Huntingtin associates with acidic phospholipids at the plasma membrane. J. Biol. Chem. 280, 36464-36473 (Pubitemid 41633920)
84. DiFiglia, M., Sena-Esteves, M., Chase, K., Sapp, E., Pfister, E., Sass, M., Yoder, J., Reeves, P., Pandey, R. K., Rajeev, K. G., Manoharan, M., Sah, D. W., Zamore, P. D., and Aronin, N. (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. U.S.A. 104, 17204-17209 (Pubitemid 350211015)